의료용 폴리머 시장 보고서(2026년)
Medical Polymers Global Market Report 2026
상품코드 : 1927003
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,496,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,390,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,284,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

의료용 폴리머 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 263억 4,000만 달러에서 2026년에는 291억 7,000만 달러로, CAGR 10.7%로 성장이 전망되고 있습니다. 지난 수년간의 성장은 의료 인프라 확충, 일회용 의료기기 생산 증가, 감염관리 재료 수요 증가, 의료용 튜브 및 포장재 사용 증가, 고분자 가공 기술 발전 등에 기인한 것으로 보입니다.

의료용 폴리머 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 443억 7,000만 달러에 달하며, CAGR은 11.1%에 달할 전망입니다. 예측 기간 중의 성장에는 첨단 임플란트 재료에 대한 수요 증가, 지속가능한 의료용 폴리머에 대한 관심 증가, 정밀의료 응용 분야 확대, 폴리머 기반 약물전달 시스템에 대한 투자 증가, 규제 당국의 재료 안전에 대한 관심 증가 등이 주요 요인으로 작용할 것으로 보입니다. 예측 기간 중 주요 동향으로는 생체적합성 및 생체흡수성 폴리머의 사용 확대, 고성능 의료용 소재에 대한 수요 증가, 일회용 의료기기의 채용 증가, 약물전달 시스템에서의 폴리머 적용 확대, 규제 준수 폴리머 제제에 대한 집중도 강화 등을 들 수 있습니다.

향후 만성질환의 유병률 증가가 의료용 폴리머 시장의 성장을 촉진할 것으로 예측됩니다. 만성질환은 1년 이상 지속되고, 지속적인 치료가 필요하며, 일상생활을 제한하는 질환을 말합니다. 예를 들어 심장병, 암, 비만, 당뇨병 등을 들 수 있습니다. 의료용 고분자는 생체적합성과 장기 안정성을 가지고 있으며, 임플란트, 약물전달시스템, 내구성 의료장비를 통한 만성질환 관리에 널리 활용되어 치료 효과와 환자의 삶의 질 향상에 기여하고 있습니다. 예를 들어 2025년 4월 미국 연방기관인 질병통제예방센터(CDC)가 발표한 보고서에 따르면 2023년 기준 미국 성인의 약 1억 9,400만 명(76.4%)이 적어도 한 가지 이상의 만성질환을 앓고 있으며, 젊은 성인의 유병률은 59.5%, 중장년층은 78.4%, 노년층은 93.0%를 보일 것으로 예측됩니다. 노인에서는 93.0%에 달했습니다. 이러한 만성질환 증가 추세는 의료용 폴리머 시장의 성장을 촉진하고 있습니다.

의료용 고분자 재료의 혁신은 의료용 고분자 시장에서 두드러진 추세입니다. 이 분야의 기업은 경쟁 우위를 유지하기 위해 혁신적인 소재 개발을 적극적으로 추진하고 있습니다. 예를 들어 2024년 9월, 미국에 본사를 둔 플라스틱 제조 기업인 Americhem Inc.는 ColorRx 의료용 폴리머 제품 라인을 출시했습니다. 이번 신제품은 신뢰할 수 있는 고품질의 지속가능한 폴리머 솔루션을 제공함으로써 유럽 의료 시장의 변화하는 요구에 부응합니다. 이러한 노력은 의료기기의 고품질 폴리머 소재에 대한 수요 증가에 대응하고, 정밀한 소재 선택, 맞춤형 컴파운드 설계, 생산 공정 전반에 걸친 일관된 색조 등 의료 현장의 까다로운 요구 사항을 충족하는 최첨단 제품을 개발할 수 있도록 합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

A medical polymer is a chemical substance characterized by molecules linked in extended, repetitive chains. Their unique properties make them adaptable for a variety of medical applications. These polymers are tailored to meet the specific requirements of the healthcare industry, including attributes such as biocompatibility, stability, and resistance to various environmental factors.

The main products within the category of medical polymers include fibers and resins, medical elastomers, biodegradable polymers, and others. Fibers consist of chemically stable polymers arranged in a sequence of monomers. They find applications in various areas, including medical components, orthopedic soft goods, wound care, cleanroom supplies, biopharma devices, and more. These products are utilized across different end-user industries, including hospitals and clinics, ambulatory surgical centers, research and academic institutes, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the medical polymers market by increasing costs of imported specialty resins, additives, processing equipment, and medical-grade raw materials. Healthcare manufacturers in North America and Europe are most affected due to dependence on imported high-purity polymers, while Asia-Pacific faces cost pressure on export-oriented medical component production. These tariffs are raising manufacturing costs and affecting pricing of medical devices. However, they are also encouraging domestic polymer production, localized compounding facilities, and innovation in cost-effective medical-grade polymer formulations.

The medical polymers market research report is one of a series of new reports from The Business Research Company that provides medical polymers market statistics, including medical polymers industry global market size, regional shares, competitors with a medical polymers market share, detailed medical polymers market segments, market trends and opportunities, and any further data you may need to thrive in the medical polymers industry. This medical polymers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical polymers market size has grown rapidly in recent years. It will grow from $26.34 billion in 2025 to $29.17 billion in 2026 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to expansion of healthcare infrastructure, increasing production of disposable medical devices, rising demand for infection control materials, growth in medical tubing and packaging usage, advancements in polymer processing technologies.

The medical polymers market size is expected to see rapid growth in the next few years. It will grow to $44.37 billion in 2030 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to increasing demand for advanced implantable materials, rising focus on sustainable medical polymers, expansion of precision medicine applications, growing investments in polymer-based drug delivery, increasing regulatory emphasis on material safety. Major trends in the forecast period include growing use of biocompatible and bioabsorbable polymers, rising demand for high-performance medical-grade materials, increasing adoption in single-use medical devices, expansion of polymer applications in drug delivery systems, enhanced focus on regulatory-compliant polymer formulations.

The increasing prevalence of chronic diseases is expected to drive the growth of the medical polymer market going forward. Chronic diseases are conditions that last for a year or longer, requiring ongoing medical care and often limiting daily activities. Examples include heart disease, cancer, obesity, and diabetes. Medical polymers are widely used in managing chronic diseases through implants, drug delivery systems, and durable medical devices due to their biocompatibility and long-term stability, which enhance treatment effectiveness and patient quality of life. For instance, in April 2025, the Centers for Disease Control and Prevention (CDC), a US-based federal agency, reported that in 2023, approximately 194 million U.S. adults, or 76.4%, had at least one chronic condition, with prevalence rates of 59.5% among young adults, 78.4% among midlife adults, and 93.0% among older adults. Therefore, the rising prevalence of chronic diseases is fueling the medical polymer market.

Innovation in medical polymer materials is a prominent trend in the medical polymer market. Companies in this sector are actively developing innovative materials to maintain their competitive edge. For example, in September 2024, Americhem Inc., a US-based plastics manufacturing firm, introduced its ColorRx Medical Grade Polymers product line. This launch responds to the evolving demands of the European healthcare market by providing reliable, high-quality, and sustainable polymer solutions. The initiative addresses the increasing need for premium polymer materials in medical devices, enabling clients to create cutting-edge products that meet the strict requirements of medical settings, including precise material selection, custom compound design, and consistent color throughout production.

In April 2023, Formerra, a US-based distributor of performance materials, acquired Total Polymer Solutions (TPS) for an undisclosed sum. This acquisition aims to bolster Formerra's position in the healthcare market. Additionally, the merger will enhance the company's ability to serve European customers more effectively, leveraging TPS's streamlined supply chain management and quicker go-to-market capabilities. Total Polymer Solutions is known for manufacturing custom injection molded plastics.

Major companies operating in the medical polymers market are BASF SE, Covestro AG, Dow Inc., DuPont de Nemours, Inc., Evonik Industries AG, DSM-Firmenich AG, Arkema S.A., Solvay S.A., Celanese Corporation, Saudi Basic Industries Corporation (SABIC), LG Chem Ltd., Mitsubishi Chemical Group Corporation, Kuraray Co., Ltd., Wanhua Chemical Group Co., Ltd., Toray Industries, Inc., Eastman Chemical Company, LANXESS AG, RTP Company, Inc., Teknor Apex Company, The Lubrizol Corporation

North America was the largest region in the medical polymers market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global medical polymers market report during the forecast period. The regions covered in the medical polymers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the medical polymers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The medical polymer market consists of sales of packaging materials, medical devices, implantable materials, and drug delivery systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Polymers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses medical polymers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for medical polymers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical polymers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Medical Polymers Market Characteristics

3. Medical Polymers Market Supply Chain Analysis

4. Global Medical Polymers Market Trends And Strategies

5. Medical Polymers Market Analysis Of End Use Industries

6. Medical Polymers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Medical Polymers Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Medical Polymers Total Addressable Market (TAM) Analysis for the Market

9. Medical Polymers Market Segmentation

10. Medical Polymers Market Regional And Country Analysis

11. Asia-Pacific Medical Polymers Market

12. China Medical Polymers Market

13. India Medical Polymers Market

14. Japan Medical Polymers Market

15. Australia Medical Polymers Market

16. Indonesia Medical Polymers Market

17. South Korea Medical Polymers Market

18. Taiwan Medical Polymers Market

19. South East Asia Medical Polymers Market

20. Western Europe Medical Polymers Market

21. UK Medical Polymers Market

22. Germany Medical Polymers Market

23. France Medical Polymers Market

24. Italy Medical Polymers Market

25. Spain Medical Polymers Market

26. Eastern Europe Medical Polymers Market

27. Russia Medical Polymers Market

28. North America Medical Polymers Market

29. USA Medical Polymers Market

30. Canada Medical Polymers Market

31. South America Medical Polymers Market

32. Brazil Medical Polymers Market

33. Middle East Medical Polymers Market

34. Africa Medical Polymers Market

35. Medical Polymers Market Regulatory and Investment Landscape

36. Medical Polymers Market Competitive Landscape And Company Profiles

37. Medical Polymers Market Other Major And Innovative Companies

38. Global Medical Polymers Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Medical Polymers Market

40. Medical Polymers Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기